Preparation method of larotinib intermediate, and intermediate compound
The invention discloses a preparation method of a larotinib intermediate represented by V, and an intermediate compound. The method comprises the following steps: taking 2,5-difluorobromobenzene and N-tert-butoxycarbonyl-L-pyroglutamate as initial raw materials, and carrying out coupling, deprotecti...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a preparation method of a larotinib intermediate represented by V, and an intermediate compound. The method comprises the following steps: taking 2,5-difluorobromobenzene and N-tert-butoxycarbonyl-L-pyroglutamate as initial raw materials, and carrying out coupling, deprotection group cyclization, reduction and decarboxylation to obtain a compound represented by a formula V.According to the invention, the preparation method has the advantages of novelty, low cost, cheap and easily available raw materials and high yield, and is suitable for large-scale industrial production.
本发明公开了一种如V所示拉罗替尼中间体的制备方法以及中间体化合物,该方法包括以2,5-二氟溴苯与N-叔丁氧羰基-L-焦谷氨酸酯为起始原料,进行偶联,脱保护基关环,还原,脱羧得到式V所示的化合物。本发明的制备方法新颖,成本低,原料廉价易得,产率高,适于大规模工业化生产。 |
---|